These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 25176592

  • 1. Novel transcatheter closure of an iatrogenic perimembranous ventricular septal defect.
    Retzer EM, Dill KE, Shah AP.
    Catheter Cardiovasc Interv; 2015 Jan 01; 85(1):161-5. PubMed ID: 25176592
    [Abstract] [Full Text] [Related]

  • 2. Transcatheter membranous ventricular septal defect closure through a mechanical aortic prosthesis using the Amplatzer membranous ventricular septal defect occluder.
    Noble S, Ibrahim R.
    Catheter Cardiovasc Interv; 2009 Feb 01; 73(2):167-72. PubMed ID: 19085913
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous closure of an iatrogenic ventricular septal defect following mechanical aortic valve replacement using the transseptal technique.
    Klein AJ, Garcia JA, Carroll JD.
    Catheter Cardiovasc Interv; 2007 Dec 01; 70(7):1018-24. PubMed ID: 17621666
    [Abstract] [Full Text] [Related]

  • 4. Transcatheter Closure of Iatrogenic VSDs after Aortic Valve Replacement Surgery: 2 Case Reports and a Literature Review.
    Taleyratne JD, Henderson RA.
    Tex Heart Inst J; 2016 Aug 01; 43(4):329-33. PubMed ID: 27547145
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous Ventricular Septal Defect Closure After Sapien 3 Transcatheter Aortic Valve Replacement.
    Mark SD, Prasanna V, Ferrari VA, Herrmann HC.
    JACC Cardiovasc Interv; 2015 Jun 01; 8(7):e109-10. PubMed ID: 26003030
    [No Abstract] [Full Text] [Related]

  • 6. Transcatheter closure of an iatrogenic ventricular septal defect after SAPIEN valve implantation.
    Levi DS, Salem M, Suh W.
    Catheter Cardiovasc Interv; 2015 Feb 15; 85(3):E90-4. PubMed ID: 24753435
    [Abstract] [Full Text] [Related]

  • 7. Treatment of an unusual complication of transfemoral TAVI with a new technique: successful occlusion of ventricular septal defect by opening the closure device in the ascending aorta.
    Dursun H, Erdal C, Ergene O, Unal B, Tanriverdi Z, Kaya D.
    Cardiovasc J Afr; 2015 Feb 15; 26(1):e8-10. PubMed ID: 25633372
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous treatment of a post-TAVI ventricular septal defect: a successful combined procedure for an unusual complication.
    Gerckens U, Latsios G, Pizzulli L.
    Catheter Cardiovasc Interv; 2013 Jun 01; 81(7):E274-7. PubMed ID: 22581693
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transcatheter closure of a traumatic VSD in an adult requiring an ASD occluder device.
    Suh WM, Kern MJ.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1120-5. PubMed ID: 19642200
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transcatheter closure of a traumatic ventricular septal defect using an Amplatzer™ atrial septal occluder device.
    Ali TA, Fatimi SH, Hasan BS.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):569-73. PubMed ID: 23483660
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antegrade transcatheter mitral valve-in-valve implantation with combined atrial septal defect closure.
    Fuchs FC, Hammerstingl C, Sinning JM, Mellert F, Werner N, Grube E, Nickenig G.
    Clin Res Cardiol; 2016 May 01; 105(5):460-2. PubMed ID: 26552904
    [No Abstract] [Full Text] [Related]

  • 15. Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adult patients.
    Al-Kashkari W, Balan P, Kavinsky CJ, Cao QL, Hijazi ZM.
    Catheter Cardiovasc Interv; 2011 Feb 01; 77(2):260-7. PubMed ID: 20853354
    [Abstract] [Full Text] [Related]

  • 16. Iatrogenic Atrial Septal Defect.
    Alkhouli M, Sarraf M, Holmes DR.
    Circ Cardiovasc Interv; 2016 Apr 01; 9(4):e003545. PubMed ID: 27056767
    [No Abstract] [Full Text] [Related]

  • 17. Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2.
    Velasco-Sanchez D, Tzikas A, Ibrahim R, Miró J.
    Catheter Cardiovasc Interv; 2013 Sep 01; 82(3):474-9. PubMed ID: 22431366
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Device closure of iatrogenic membranous ventricular septal defects after prosthetic aortic valve replacement using the Amplatzer membranous ventricular septal defect occluder.
    Holzer R, Latson L, Hijazi ZM.
    Catheter Cardiovasc Interv; 2004 Jun 01; 62(2):276-80. PubMed ID: 15170726
    [Abstract] [Full Text] [Related]

  • 20. Iatrogenic atrial septal defect closure after transseptal mitral valve interventions: Indications and outcomes.
    Beri N, Singh GD, Smith TW, Fan D, Boyd WD, Rogers JH.
    Catheter Cardiovasc Interv; 2019 Nov 15; 94(6):829-836. PubMed ID: 31001927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.